Analysis of hCG: Clinical Applications and Assay Requirements

Hirose T. Exogenous stimulation of corpus luteum formation in the rabbit; influence of extracts of human placenta, decidua, fetus, hydatid mole and corpus luteum on the rabbit gonad. J Jpn Gynecol Soc 1920; 16: 1055.

Bagshawe KD . Recent observations related to the chemotherapy and immunology of gestational choriocarcinoma. Adv Cancer Res 1973; 18: 231–63.

Jameson JL Hollenberg AN . Regulation of chorionic gonadotropin gene expression. Endocr Rev 1993; 14: 203–21.

Bidart J-M Bellet D. Human chorionic gonadotropin molecular forms, detection and clinical implications. Trends Endocrinol Metab 1993; 4: 285–91.

O'Connor JF Birken S Lustbader JW Krichevsky A Chen Y Canfield RE . Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: Impact on clinical measurements. Endocr Rev 1994; 15: 650–83.

Stenman U-H Alfthan H. hCG determinations: What does the clinician need and what can the laboratory provide? In: Sturgeon CM Seth J Middle JG Halloran SP , eds. Proceedings of the UK NEQAS Endocrinology Meeting, 1994 Apr 11–14. Edinburgh. London: Association of Clinical Biochemists, 1995: 94–103.

Stenman U-H Bidart J-M Birken S Mann K Nisula B O'Connor J. Standardization of protein immunoprocedures. Choriogonadotropin (CG). Scand J Clin Lab Invest 1993; 53 Suppl 216: 42–78.

Canadian Society of Clinical Chemists. Canadian Society of Clinical Chemists Position Paper: Standardization of selected polypeptide hormone measurements. Clin Biochem 1992; 25: 415–24.

National Committee for Clinical Laboratory Standards. Choriogonadotropin testing: Nomenclature, reference preparations, assay performance, and clinical application; approved guideline. NCCLS Document I/LA10-A. Wayne, PA: NCCLS, 1996.

Norman RJ Buck RH De Medeiros SF . Measurement of human chorionic gonadotrophin (hCG): Indications and techniques for the clinical laboratory. Ann Clin Biochem 1990; 27: 183–94.

Lapthorn AJ Harris DC Littlejohn A Lustbader JW Canfield RE Machin KJ Crystal structure of human chorionic gonadotrophin. Nature 1994; 369: 455–61.

Berger P Bidart J-M Delves PS Dirnhofer S Hoermann R Isaacs N Immunochemical mapping of gonadotropins. Mol Cell Endocrinol 1996; 125: 33–43.

Birken S Kovalevskaya G O'Connor J. Metabolism of hCG and hLH to multiple urinary forms. Mol Cell Endocrinol 1996; 125: 121–31.

Gambino R. Human chorionic gonadotropin: Multiple degradation products confound assays. Lab Medica Int 1996; July/August: 18–9.

Skarulis MC Wehmann RE Nisula BC Blithe DL . Glycosylation changes in human chorionic gonadotropin and free alpha subunit as gestation progresses. J Clin Endocrinol Metab 1992; 75: 91–6.

Hoermann R Spoettle G Grossmann M Saller B Mann K. Molecular heterogeneity of human chorionic gonadotropin in serum and urine from patients with trophoblastic tumours. Clin Invest 1993; 71: 953–60.

Immunoassay Kit Directory (Peptide Hormones), Vol 3. Norwell, MA: Kluwer Academic Publishers 1994.

Alfthan H Haglund C Dabek J Stenman U-H. Concentrations of hCG, βhCG, and cβhCG in serum and urine of nonpregnant women and men. Clin Chem 1992; 38: 1981–7.

Ozturk M Bellet D Manil L Hennen G Frydman R Wands JR . Physiological studies of human chorionic gonadotropin (hCG), αhCG and βhCG as measured by specific monoclonal immunoradiometric assays. Endocrinology 1987; 120: 549–58.

Korhonen J Alfthan H Ylöstalo P Veldhuis J Stenman U-H. Disappearance of human chorionic gonadotropin and its α-and β-subunits after term pregnancy. Clin Chem 1997; 43: 2155–63.

Alfthan H Björses U-M Tiitinen A Stenman U-H. Specificity and detection limit of ten pregnancy tests. Scand J Clin Lab Invest 1993; 216S: 105–13.

Mishalani SH Seliktar J Braunstein GD . Four rapid serum—urine combination assays of choriogonadotropin (hCG) compared and assessed for their utility in quantitative determinations of hCG. Clin Chem 1994; 40: 1944–9.

Uribe MA Dunn RC . Tubal pregnancy with normal hysterosalpingogram and negative serum pregnancy test. Obstet Gynecol 1990; 75: 483–5.

Cacciatore B Stenman U-H Ylöstalo P. Diagnosis of ectopic pregnancy by vaginal ultrasonography in combination with a discriminatory serum hCG level of 1000 IU/L (IRP). Br J Obstet Gynaecol 1990; 97: 904–8.

Steier JA Bergsio PA Myking OL . Human chorionic gonadotrophin in maternal plasma after induced abortion, spontaneous abortion and removed ectopic pregnancy. Obstet Gynecol 1984; 64: 391–4.

Mascarenhas L Williamson J Smith S. The changing face of ectopic pregnancy. BMJ 1997; 315: 141.

Yao ML Tulandi T. Current status of surgical and non-surgical management of ectopic pregnancy. Fertil Steril 1997; 67: 421–33.

Trio D Lapinski RH Strobelt N Ghidini A Picciolo C. Prognostic factors for successful expectant management of ectopic pregnancy. Fertil Steril 1995; 63: 469–72.

Korhonen J Stenman U-H Ylöstalo P. Serum human chorionic gonadotropin dynamics during spontaneous resolution of ectopic pregnancy. Fertil Steril 1994; 61: 632–6.

Korell M Strowitzki T Hepp H. Diagnosis and treatment of ectopic pregnancy. Gynakol Geburtshilfliche Rundsch 1996; 36: 138–42.

Klein M Husslein P. Basis and effects of local drug therapy in tubal pregnancies. Gynakol Geburtshilfliche Rundsch 1996; 36: 133–7.

Gross Z Rodriguez JJ Stalnaker BL . Ectopic pregnancy—nonsurgical, outpatient evaluation and single-dose methotrexate treatment. J Reprod Med 1995; 40: 371–4.

Sauer MV Vidali A James W. Treating persistent ectopic pregnancy by methotrexate using a sliding scale: Preliminary experience. J Gynecol Surg 1997; 13: 13–6.

Cacciatore B Stenman U-H Ylöstalo P. Early screening for ectopic pregnancy in high-risk symptom-free women. Lancet 1994; 343: 517–8.

Chard T Macintosh MCM . Biochemical screening for Down's syndrome. J Clin Lig Assay 1995; 18: 126–34.

Grudzinskas JG Chard T Chapman M Cuckle H , eds. Screening for Down's Syndrome. Cambridge: Cambridge University Press, 1994.

Spencer K Coombes EJ Mallard AS Milford-Ward A. Free beta human choriogonadotropin in Down's syndrome screening: A multicentre study of its role compared with other biochemical markers. Ann Clin Biochem 1992; 29: 506–18.

Wald N Densem J Stone R Cheng R. The use of free β-hCG in antenatal screening for Down's syndrome. Br J Obstet Gynaecol 1993; 100: 550–7.

Cuckle H Iles RK Chard T. Urinary beta-core human chorionic gonadotrophin: A new approach to Down's syndrome screening. Prenat Diagn 1994; 14: 953–8.

Iles RK . Urinary analysis for Down's syndrome: Is the measurement of urinary beta-core the future of biochemical screening for Down's syndrome? Early Hum Devel 1996; 47: S41–5.

Cole LA Kohorn EI Kim GS . Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels. J Reprod Med 1994; 39: 193–200.

Bagshawe KD Dent J Webb J. Hydatidiform mole in England and Wales, 1973–1983. Lancet 1986; ii: 673–7.

Newlands ES . Presentation and management of persistent gestational trophoblastic disease and gestational trophoblastic tumours in the UK. In: Hancock WB Newlands ES Berkowitz RS , eds. Gestational Trophoblastic Disease. London: Chapman & Hall, 1997: 143–58.

Yedema KA Verheijen RH Kenemans P Schijf CP Borm GF Segers MF Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve. Am J Obstet Gynecol 1993; 168: 787–92.

Creinin MD Edwards J. Early abortion: Surgical and medical options. Curr Probl Obst Gynecol Fertil 1997; 20: 6–32.

Doherty AP Bower M Christmas TJ . The role of tumour markers in the diagnosis and treatment of testicular germ cell cancers. Br J Urol 1997; 79: 247–52.

Mann K Saller B Hoermann R. Clinical use of hCG and hCGβ determinations. Scand J Clin Lab Invest 1993; 53 Suppl 216: 97–104.

Schutter EMJ Mulder C Van Kamp GJ Kenemans P. The beta-core fragment of human chorionic gonadotropin: Biochemical background and clinical application. Anticancer Res 1997; 17: 1255–72.

Braunstein GD Grodin JM Vaitukaitis JL Ross GT . Secretory rates of human chorionic gonadotropin by normal trophoblast. Am J Obstet Gynecol 1973; 115: 447–50.

Khazaeli MB Buchina ES Pattillo RA Soong S-J Hatch KD . Radioimmunoassay of the free β-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease. Am J Obstet Gynecol 1989; 160: 444–9.

Saller B Clara R Spoettl G Siddle K Mann K. Testicular cancer secretes intact human choriogonadotropin (hCG) and its free β-subunit: Evidence that hCG (+ hCGβ) assays are the most reliable in diagnosis and follow-up. Clin Chem 1990; 36: 234–9.

Marcillac I Troalen F Bidart J-M Ghilkani P Ribrag V Escudier B Free human chorionic gonadotropin β subunit in gonadal and non-gonadal neoplasms. Cancer Res 1992; 52: 3901–7.

Scottish Intercollegiate Guidelines Network (SIGN): Management of adult testicular germ cell tumours. Edinburgh: SIGN, 1998 (in press).

Cole LA Tanaka A Kim GS Park SY Kohn MW Schwartz PE Beta-core fragment (beta-core/UGF/UGP), a tumor marker—A 7-year report. Gynecol Oncol 1996; 60: 264–70.

Alfthan H Haglund C Roberts P Stenman U-H. Elevation of free β-subunit of human choriogonadotropin and core β fragment of human choriogonadotropin in serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 1992; 52: 4628–33.

Iles RK Lee CL Oliver RTD Chard T. Composition of intact hormone and free subunits in the human chorionic gonadotrophin-like material found in serum and urine of patients with carcinoma of the bladder. Clin Endocrinol 1990; 33: 355–64.

Alfthan H Stenman U-H. Pathophysiological importance of various molecular forms of human choriogonadotropin. Mol Cell Endocrinol 1996; 125: 107–20.

Birken S Kovalevskaya G O'Connor J. Metabolism of hCG and hLH to multiple urinary forms. Mol Cell Endocrinol 1996; 125: 121–31.

George A. The anabolic steroids and peptide hormones. In: Mottram DR , ed. Drugs in Sport. London: E & FN Spon, 1996: 173–215.

Laidler P Cowan DA Hider RC Kicman AT . New decision limits and quality control materials for detecting human chorionic gonadotropin misuse in sport. Clin Chem 1994; 40: 1306–11.

Stenman U-H Unkila-Kallio L Korhonen J Alfthan H. Immunoprocedures for detecting human chorionic gonadotropin: Clinical aspects and doping control. Clin Chem 1997; 43: 1293–8.

Liu C Bowers LD . Mass spectrometric characterization of nicked fragments of the β-subunit of human chorionic gonadotropin. Clin Chem 1997; 43: 1172–81.

Sebástian-Gámbaro MA Lirón-Hernández FJ Fuentes-Arderiu X. Intra- and inter-individual biological variability data bank. Eur J Clin Chem Clin Biochem 1997; 35: 845–52.

Jeffcoate SL . Analytical and clinical significance of peptide hormone heterogeneity with particular reference to growth hormone and luteinizing hormone in serum. Clin Endocr 1993; 38: 113–21.

Storring PL . Assaying glycoprotein hormones—the influence of glycosylation on immunoreactivity. Trends Biotechnol 1992; 10: 427–32.

Seth J. Standardization of protein hormone immunoassays. Ann Clin Biochem 1996; 33: 482–5.

Stenman U-H. Standardisation of immunoassays. In: Price CP Newman DJ , eds. Principles and Practice of Immunoassay, 2nd edn. Basingstoke: Macmillan Press Ltd, 1997: 243–68.

Ekins RP . Immunoassay Standardisation. Proceedings of the 3rd IFCC/Bergmeyer Conference on Improvement of Comparability of Laboratory Assay Results in Life Sciences. Scand J Clin Lab Invest 1991; 51 Suppl 205: 33–46.

Storring PL Gaines-Das RE Bangham DR . International reference preparation of human chorionic gonadotrophin for immunoassay: Potency estimates in various bioassay and protein binding assay systems; and international reference preparations of α and β subunits of human chorionic gonadotrophin for immunoassay. J Endocrinol 1980; 84: 295–310.

Wide L Gemzell CA . An immunological pregnancy test. Acta Endocrinol 1960; 36: 261–7.

Robertson WR Lambert A Mitchell R Talbot JA . The interpretation of immuno- and bioassays of human follicle stimulating hormone. In: Fauser BJCM Coelinth-Bennink H Evers JLH Rommerts FFG Schoemaker J Velde ER , eds. FSH Action and Intra-ovarian Regulation. Carnforth: Parthenon Press, 1997.

Dufau ML Pock R Neubauer A Catt KJ . In vitro bioassay of LH in human serum: The rat interstitial cell testosterone (RICT) assay. J Clin Endocrinol Metab 1976; 42: 958–69.

Van Damme MP Robertson DM Diczfalusy E. An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations. Acta Endocrinol (Copenh) 1974; 77: 655–71.

Kraiem Z Sadeh O Yosef M. Iodide uptake and organification, tri-iodothyronine secretion, cyclic AMP accumulation and cell proliferation in an optimized system of human thyroid follicles cultured in collagen suspended in serum-free medium. J Endocrinol 1991; 131: 499–506.

Nisula BC . Measurement of human chorion gonadotropin by biological methods. Scand J Clin Lab Invest 1993; 53 Suppl 216: 114–7.

Chard T. Pregnancy tests: A review. Hum Reprod 1992; 7: 701–10.

Kardana A Cole LA . Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free β-subunit. Clin Chem 1992; 38: 26–33.

Cole LA Kardana A. Discordant results in human chorionic gonadotropin assays. Clin Chem 1992; 38: 263–70.

Daviaud J Fournet D Ballongue C Guillem G-P Leblanc A Casellas C Reliability and feasibility of pregnancy home-use tests: Laboratory validation and diagnostic evaluation by 638 volunteers. Clin Chem 1993; 39: 53–9.

Chard T. An Introduction to Radioimmunoassay and Related Techniques, 4th edn. Amsterdam: Elsevier, 1990.

Price CP Newman DJ , eds. Principles and Practice of Immunoassay, 2nd edn. Basingstoke: MacMillan Press Ltd, 1997.

Wild D , ed. The Immunoassay Handbook. Basingstoke: Macmillan Press Ltd, 1994.

Seth J Sturgeon CM Ellis AR . Annual Reviews of the UK NEQAS for Peptide Hormones and Related Substances. Edinburgh: UK NEQAS 1994, 1995, 1996, 1997.

Hollis S. Analysis of method comparison studies. Ann Clin Biochem 1996; 33: 1–4.

Strike PW . Measurement in Laboratory Medicine. Oxford: Butterworth Heinemann Ltd, 1996.

National Committee for Clinical Laboratory Standards. Evaluation of Precision Performance of Clinical Chemistry Devices—Second Edition; Tentative Guidelines. NCCLS; Document EP5-T2. Wayne, PA: NCCLS, 1992.

Bidart J-M. Functional mapping of proteins with monoclonal antibodies. In: Gosling JP Green DJ , eds. Immunotechnology. London: Portland Press, 1993: 77–89.

Sturgeon CM Seth J. Why do immunoassays for tumour markers give differing results?—A view from the UK National External Quality Assessment Schemes. Eur J Clin Chem Clin Biochem 1996; 34: 755–9.

Kardana A Cole LA . Human chorionic gonadotropin β-subunit nicking enzymes in pregnancy and cancer patient serum. J Clin Endocrinol Metab 1994; 79: 761–7.

Weber TH Käpyaho KI Tanner P. Endogenous interference in immunoassays in clinical chemistry. A review. Scand J Clin Lab Invest 1990; 50 Suppl 201: 77–82.

Seth J Sturgeon CM . Pitfalls in immunoassays in endocrinology. AACC Endo 1993; 11: 89–106.

Remaley AT Bulley M Senior MB Goodman DBP . Discordant hCG measurements in a patient with a carcinoma. Clin Chem 1989; 35: 1259–60.

Germa JR Arcusa A Casamitjana R. False elevations of human chorionic gonadotropin associated with iatrogenic hypogonadism in gonadal germ cell tumors. Cancer 1987; 60: 2489–93.

Bulger KN Hesketh PJ Babayan RK . Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer. J Urol 1989; 142: 1574–5.

Pettersson KSI Ding Y-Q Huhtaniemi I. Monoclonal antibody-based discrepancies between two-site immunometric tests for lutropin. Clin Chem 1991; 37: 1745–8.

Taylor RN Padula C Goldsmith PC . Pitfall in the diagnosis of ectopic pregnancy: Immunocyto-chemical evaluation in a patient with false-negative serum β-hCG levels. Obstet Gynecol 1988; 71: 1035–8.

Braunstein GD Bloch SK Rasor JL Winikoff J. Characterization of anti-human chorionic gonadotropin serum antibody appearing after ovulation induction. J Clin Endocrinol Metab 1983; 57: 1164–72.

Boscato LM Stuart MC . Heterophilic antibodies: A problem for all immunoassays. Clin Chem 1988; 34: 27–33.

King IR Doody MC . False-positive hCG by enzyme-immunoassay resulting in repeat chemotherapy. Obstet Gynecol 1995; 86: 682–3.

O'Reilly SM Rustin GJS . Mismanagement of choriocarcinoma due to a false low hCG measurement. Int J Gynaecol Cancer 1993; 3: 186–8.

McAllister EJ Yosef H. Misleading serum hCG concentrations in a patient with testicular teratoma. In: Martin SM Halloran SP Green AJE , eds. Proceedings of the ACB National Meeting, 1995 May 15–19, Glasgow. London: Association of Clinical Biochemists, 1995: 172.

Bidart J-M Troalen F Lazar V Vauzelle P Bellet D. Pitfalls in measuring choriogonadotropin and its free subunits in decomplemented sera. Clin Chem 1991; 37: 1467–8.

Börmer O. Interference of complement with the binding of carcinoembryonic antigen to solid-phase monoclonal antibodies. J Immunol Methods 1989; 121: 85–93.

Ellis AR Seth J Sturgeon CM Al-Sadie R. UK NEQAS for peptide hormones and related substances—scheme highlights. In: Sturgeon CM Seth J Middle JG Halloran SP , eds. Proceedings of the UK NEQAS Endocrinology Meeting, 1996 31 Mar-3 Apr, Cardiff. London: Association of Clinical Biochemists, 1997: 121–9.

Hoffman KL Parsons GH Allerdt LJ . A very rapid and highly sensitive qualitative and quantitative assay for hCG. Clin Chem 1984; 30: 1047.

Kent A Kitau MJ Chard T. Absence of diurnal variation in urinary chorionic gonadotrophin excretion at 8–13 weeks gestation. Br J Obstet Gynaecol 1991; 98: 1180–1.

Rao CV Hussa RO Carmen FR Rinke ML Cook CL Yussman MA . Stability of human chorionic gonadotropin and its α subunit in human blood. Am J Obstet Gynecol 1983; 146: 65–8.

Spencer K Macri JN Carpenter P Anderson R Krantz DA . Stability of intact chorionic gonadotropin (hCG) in serum, liquid whole blood and dried whole blood filter paper spots: Impact on screening for Down's syndrome by measurement of free beta-hCG subunit. Clin Chem 1993; 39: 1064–8.

Lantz ME O'Brien WF Williams MC . The effect of sample preparation and storage on maternal triple marker screening. Obstet Gynecol 1995; 85: 919–23.

Sturgeon CM Seth J Al-Sadie R. UK EQAS for CEA and hCG: Aims and achievements. Commun Lab Med 1992; 3: 37–40.

Ozturk M Brown N Milunsky A Wands J. Physiological studies of human chorionic gonadotropin and free subunits in the amniotic fluid compartment compared to those in maternal serum. J Clin Endocrinol Metab 1988; 67: 1117–21.

Iles RK Wathen NC Campbell DJ Chard T. Human chorionic gonadotrophin and subunit composition of maternal serum and coelomic and amniotic fluids in the first trimester of pregnancy. J Endocrinol 1992; 135: 563–9.

Bagshawe KD Harland S. Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system. Cancer 1976; 38: 112–8.

Honegger J Mann K Thierauf P Zrinzo A Fahlbusch R. Human chorionic gonadotrophin immunoactivity in cystic intracranial tumours. Clin Endocrinol 1995; 42: 235–41.

Hoermann R Gerbes AL Spoettl G Jüngst D Mann K. Immunoreactive human chorionic gonadotropin and its free β-subunit in serum and ascites of patients with malignant tumors. Cancer Res 1992; 52: 1520–4.

Grossmann M Hoermann R Gocze PM Ott M Berger P Mann K. Measurement of human chorionic gonadotropin-related immunoreactivity in serum, ascites and tumor cysts of patients with gynaecological malignancies. Eur J Clin Invest 1995; 25: 867–73.

Gerbes AL Hoermann R Mann K Jüngst D. Human chorionic gonadotropin-beta in the differentiation of malignancy-related and non-malignant ascites. Digestion 1996; 57: 113–7.

Seth J. Quality assurance. In: Price CP Newman DJ , eds. Principles and Practice of Immunoassay, 2nd edn. Basingstoke: MacMillan Press Ltd, 1997: 210–41.

Westgard JO Klee GG . Quality management. In: Burtis CA Ashwood ER , eds. Tietz Textbook of Clinical Chemistry, 2nd edn. Philadelphia: WB Saunders Co, 1994: 548–92.

National Committee for Clinical Laboratory Standards. Internal quality control testing: Principles and definitions: Approved guideline. NCCLS Document C24-A. Wayne, PA: NCCLS, 1991.

Dept of Health and Human Services. Medicare, Medicaid and CLIA Programs: Regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Final Rule. Federal Register 1992; 57: 7002–186.

Kruse R Geilenkeuser W-J Röhle G. Inter-laboratory surveys of the determination of tumour markers: Scatter and repeatability of results. Eur J Clin Chem Clin Biochem 1993; 31: 139–46.

Pilo A Zucchelli GC Chiesa MR Masini S Clerico A. The CNR External Quality Assessment program for immunoassays: Statistical analysis and reports for participants. Ann Ist Super Sanità 1991; 27: 469–78.

Seth J Sturgeon CM Al-Sadie R Hanning I Ellis AR . External quality assessment of immunoassays of peptide hormones and tumour markers: Principles and practice. Ann Ist Super Sanità 1991; 27: 359–64.

Proposal for a European Parliament and Council Directive on in vitro diagnostic medical devices. Official Journal of the European Communities 7 July 1995, NoC172/21-44.

Sturgeon CM Seth J Ellis AR . Clinical interpretation of laboratory results. In: Sturgeon CM Seth J Middle JG Halloran SP , eds. Proceedings of the UK NEQAS Endocrinology Meeting, 1996 31 Mar-3 Apr, Cardiff. London: Association of Clinical Biochemists, 1997: 110–5.